John L Workman
CIK 1302537 · View on SEC EDGAR ↗
Insider
First SEC filing: July 1, 2015 · Latest: Feb. 8, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 74 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
74 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 2, 2020 | CNMD | P | 2,000 | $94.63 | $189,260 | 16,035 Direct | +14.25% | Acquired | -45.6% (price as of 2026-08-19) |
| March 2, 2016 | CNMD | P | 2,500 | $39.85 | $99,625 | 4,500 Direct | +125.00% | Acquired | 29.1% (price as of 2026-08-19) |
| July 28, 2015 | CNMD | P | 100 | $57.88 | $5,788 | 2,000 Direct | +5.26% | Acquired | -11.1% (price as of 2026-08-19) |
| July 28, 2015 | CNMD | P | 1,900 | $57.83 | $109,877 | 1,900 Direct | — | Acquired | -11.0% (price as of 2026-08-19) |
| Nov. 10, 2008 | EHC | P | 1,400 | $11.76 | $16,464 | 96,705 Direct | +1.47% | Acquired | 1214.2% (price as of 2026-08-19) |
| Nov. 10, 2008 | EHC | P | 2,400 | $11.78 | $28,272 | 95,305 Direct | +2.58% | Acquired | 1212.0% (price as of 2026-08-19) |
| Nov. 10, 2008 | EHC | P | 300 | $11.74 | $3,522 | 92,905 Direct | +0.32% | Acquired | 1216.4% (price as of 2026-08-19) |
| Nov. 10, 2008 | EHC | P | 800 | $11.76 | $9,408 | 92,605 Direct | +0.87% | Acquired | 1214.2% (price as of 2026-08-19) |
| Nov. 10, 2008 | EHC | P | 100 | $11.75 | $1,175 | 91,805 Direct | +0.11% | Acquired | 1215.3% (price as of 2026-08-19) |
| Nov. 16, 2007 | EHC | P | 35 | $19.98 | $699 | 100,639 Direct | +0.03% | Acquired | 673.5% (price as of 2026-08-19) |
| Nov. 16, 2007 | EHC | P | 600 | $19.98 | $11,988 | 100,604 Direct | +0.60% | Acquired | 673.5% (price as of 2026-08-19) |
| Nov. 16, 2007 | EHC | P | 1,865 | $20.00 | $37,300 | 100,004 Direct | +1.90% | Acquired | 672.7% (price as of 2026-08-19) |
| Aug. 16, 2007 | EHC | P | 100 | $17.74 | $1,774 | 99,786 Direct | +0.10% | Acquired | 771.2% (price as of 2026-08-19) |
| Aug. 16, 2007 | EHC | P | 100 | $17.73 | $1,773 | 99,686 Direct | +0.10% | Acquired | 771.7% (price as of 2026-08-19) |
| Aug. 16, 2007 | EHC | P | 100 | $17.71 | $1,771 | 99,586 Direct | +0.10% | Acquired | 772.7% (price as of 2026-08-19) |
| Aug. 16, 2007 | EHC | P | 1,700 | $17.75 | $30,175 | 99,486 Direct | +1.74% | Acquired | 770.7% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 16 | $17.37 | $278 | 97,786 Direct | +0.02% | Acquired | 789.7% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 100 | $17.36 | $1,736 | 97,770 Direct | +0.10% | Acquired | 790.3% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 200 | $17.38 | $3,476 | 97,670 Direct | +0.21% | Acquired | 789.2% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 100 | $17.33 | $1,733 | 97,470 Direct | +0.10% | Acquired | 791.8% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 3,800 | $17.28 | $65,664 | 97,370 Direct | +4.06% | Acquired | 794.4% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 800 | $17.39 | $13,912 | 93,570 Direct | +0.86% | Acquired | 788.7% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 100 | $17.41 | $1,741 | 92,770 Direct | +0.11% | Acquired | 787.7% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 2,584 | $17.40 | $44,962 | 92,670 Direct | +2.87% | Acquired | 788.2% (price as of 2026-08-19) |
| Aug. 14, 2007 | EHC | P | 5,300 | $17.30 | $91,690 | 90,086 Direct | +6.25% | Acquired | 793.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | CNMD | RSUs (Restricted Stock Units) | Common Stock (479) | $0.00 | June 3, 2034 | 479 | Disposed |
| June 3, 2024 | CNMD | Rsus (restricted Stock Units) | Common Stock (479) | $0.00 | June 3, 2034 | 479 | Acquired |
| June 3, 2024 | CNMD | Options To Purchase Common Stock | Common Stock (5,503) | $77.18 | June 3, 2034 | 5,503 | Acquired |
| May 31, 2024 | CNMD | Rsus (restricted Stock Units) | Common Stock (302) | $0.00 | June 1, 2033 | 302 | Disposed |
| June 1, 2023 | CNMD | Options To Purchase Common Stock | Common Stock (2,826) | $123.79 | June 1, 2033 | 2,826 | Acquired |
| June 1, 2023 | CNMD | Rsus (restricted Stock Units) | Common Stock (302) | $0.00 | June 1, 2033 | 302 | Acquired |
| June 1, 2023 | CNMD | Rsus (restricted Stock Units) | Common Stock (335) | $0.00 | June 1, 2032 | 335 | Disposed |
| June 1, 2022 | CNMD | Rsus (restricted Stock Units) | Common Stock (335) | $0.00 | June 1, 2032 | 335 | Acquired |
| June 1, 2022 | CNMD | Options To Purchase Common Stock | Common Stock (3,453) | $111.79 | June 1, 2032 | 3,453 | Acquired |
| June 1, 2022 | CNMD | Rsus (restricted Stock Units) | Common Stock (812) | $0.00 | June 1, 2031 | 812 | Disposed |
| June 1, 2021 | CNMD | Options To Purchase Common Stock | Common Stock (865) | $138.45 | June 1, 2031 | 865 | Acquired |
| June 1, 2021 | CNMD | Rsus (restricted Stock Units) | Common Stock (812) | $0.00 | June 1, 2031 | 812 | Acquired |
| June 1, 2021 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,521) | $0.00 | June 1, 2030 | 1,521 | Disposed |
| June 1, 2020 | CNMD | Options To Purchase Common Stock | Common Stock (1,843) | $73.94 | June 1, 2030 | 1,843 | Acquired |
| June 1, 2020 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,521) | $0.00 | June 1, 2030 | 1,521 | Acquired |
| June 1, 2020 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,407) | $0.00 | June 3, 2029 | 1,407 | Disposed |
| June 3, 2019 | CNMD | Options To Purchase Common Stock | Common Stock (2,165) | $79.94 | June 3, 2029 | 2,165 | Acquired |
| June 3, 2019 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,407) | $0.00 | June 3, 2029 | 1,407 | Acquired |
| May 31, 2019 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,629) | $0.00 | June 1, 2028 | 1,629 | Disposed |
| June 1, 2018 | CNMD | Options To Purchase Common Stock | Common Stock (2,549) | $69.03 | June 1, 2028 | 2,549 | Acquired |
| June 1, 2018 | CNMD | Rsus (restricted Stock Units) | Common Stock (1,629) | $0.00 | June 1, 2028 | 1,629 | Acquired |
| June 1, 2018 | CNMD | Rsus (restricted Stock Units) | Common Stock (2,167) | $0.00 | June 1, 2027 | 2,167 | Disposed |
| June 1, 2017 | CNMD | Options To Purchase Common Stock | Common Stock (3,669) | $51.90 | June 1, 2027 | 3,669 | Acquired |
| June 1, 2017 | CNMD | Rsus (restricted Stock Units) | Common Stock (2,167) | $0.00 | June 1, 2027 | 2,167 | Acquired |
| June 1, 2017 | CNMD | Rsus (restricted Stock Units) | Common Stock (2,739) | $0.00 | June 1, 2026 | 2,739 | Disposed |
| June 1, 2016 | CNMD | Options To Purchase Common Stock | Common Stock (5,396) | $41.06 | June 1, 2026 | 5,396 | Acquired |
| June 1, 2016 | CNMD | Rsus (restricted Stock Units) | Common Stock (2,739) | $0.00 | June 1, 2026 | 2,739 | Acquired |
| June 1, 2016 | CNMD | Rsus (restricted Stock Units) | Common Stock (3,000) | $0.00 | July 1, 2025 | 3,000 | Disposed |
| July 1, 2015 | CNMD | Sars (Stock Appreciation Rights) | Common Stock (1,000) | $58.74 | July 1, 2025 | 1,000 | Acquired |
| July 1, 2015 | CNMD | Rsus (restricted Stock Units) | Common Stock (3,000) | $0.00 | July 1, 2025 | 3,000 | Acquired |
| Feb. 20, 2014 | FSS | Stock Option (right-to-buy) | Common Stock (5,000) | $12.69 | Feb. 20, 2024 | 5,000 | Acquired |
| Sept. 2, 2009 | EHC | Non-qualified Stock Option (Right to Buy) [F1] | Healthsouth Common Stock (17,830) | $14.95 | Sept. 2, 2019 | 17,830 | Acquired |
| Feb. 27, 2009 | EHC | Non-qualified Stock Option (Right to Buy) | Healthsouth Common Stock (55,929) | $7.85 | Feb. 27, 2019 | 55,929 | Acquired |
| Feb. 28, 2008 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (64,550) | $16.27 | Feb. 28, 2018 | 64,550 | Acquired |
| March 2, 2007 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (25,000) | $23.19 | March 2, 2017 | 25,000 | Acquired |
| March 2, 2007 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (25,000) | $23.19 | March 2, 2017 | 25,000 | Acquired |
| Feb. 23, 2006 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (110,000) | $5.31 | Feb. 23, 2016 | 110,000 | Acquired |
| Nov. 17, 2005 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (75,301) | $3.87 | Nov. 17, 2015 | 75,301 | Acquired |
| March 23, 2005 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (110,000) | $5.37 | March 23, 2015 | 110,000 | Acquired |
| Sept. 20, 2004 | EHC | Non-Qualified Stock Option (right to buy) | HEALTHSOUTH Common Stock (55,000) | $5.05 | Sept. 20, 2014 | 55,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2009 | $509,466 | $250,000 | $634,095 | $342,479 | — | — | $359,686 | $2,095,726 |
| 2008 | $608,184 | — | — | — | $569,056 | — | $147,832 | $2,420,811 |
| 2007 | $578,537 | — | $465,614 | $354,664 | $463,593 | — | $139,000 | $2,001,408 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.